CAT
55
-2
MAT
30
-2
VIX
38
-3
VRSN
66
4
PBI
42
-4
PSA
35
15
EBAY
56
3
PFE
45
-15
AAP
26
-7
VFC
59
-2
BEN
55
-2
GS
62
3
COF
47
-3
NAVI
40
2
EQT
65
-3
FIS
48
2
IR
35
-3
XYL
33
-2
EQR
25
5
MSI
47
3
CAT
55
-2
MAT
30
-2
VIX
38
-3
VRSN
66
4
PBI
42
-4
PSA
35
15
EBAY
56
3
PFE
45
-15
AAP
26
-7
VFC
59
-2
BEN
55
-2
GS
62
3
COF
47
-3
NAVI
40
2
EQT
65
-3
FIS
48
2
IR
35
-3
XYL
33
-2
EQR
25
5
MSI
47
3
Financhill
Back

The Bank of Nova Scotia Vs. Oruka Therapeutics, Inc. Industry Stock Comparison

Buy
71

BNS
The Bank of Nova Scotia

Last Price:
$70.11
Seasonality Move:
5.41%
Buy
100

ORKA
Oruka Therapeutics, Inc.

Last Price:
$53.39
Seasonality Move:
5.42%
Buy
71
The Bank of Nova Scotia (BNS) is a Buy

Is The Bank of Nova Scotia a Buy, Sell or Hold?

  • The current The Bank of Nova Scotia [BNS] share price is $70.12. The Score for BNS is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
  • BNS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
100
Oruka Therapeutics, Inc. (ORKA) is a Buy

Is Oruka Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Oruka Therapeutics, Inc. [ORKA] share price is $53.31. The Score for ORKA is 100, which is 100% above its historic median score of 50, and infers lower risk than normal.
  • ORKA is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

BNS Stock Price Chart

What is The Bank of Nova Scotia's stock price today?

  • The The Bank of Nova Scotia share price today is $70.12
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BNS is experiencing buying pressure, which is a positive indicator for future bullish movement.

ORKA Stock Price Chart

What is Oruka Therapeutics, Inc.'s stock price today?

  • The Oruka Therapeutics, Inc. share price today is $53.31
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ORKA is experiencing buying pressure, which is a positive indicator for future bullish movement.

BNS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.16 Sell
Relative Strength Index (14 RSI): 47.14 Sell
Chaikin Money Flow: 914098 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (68.38 - 72.86) Sell
Bollinger Bands (100): (69.05 - 75.29) Sell

ORKA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.1 Buy
Relative Strength Index (14 RSI): 77.59 Buy
Chaikin Money Flow: 1458349 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (33.68 - 45.6) Buy
Bollinger Bands (100): (27.9 - 38.44) Buy

BNS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 69.08 Buy
20-day SMA: 69.67 Buy
50-day SMA: 73.26 Sell
200-day SMA: 66.14 Buy
8-day EMA: 69.34 Buy
20-day EMA: 70.16 Sell
50-day EMA: 71.63 Sell
200-day EMA: 66.81 Buy

ORKA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 46.5 Buy
20-day SMA: 41.09 Buy
50-day SMA: 36.64 Buy
200-day SMA: 25.3 Buy
8-day EMA: 47.34 Buy
20-day EMA: 42.69 Buy
50-day EMA: 37.82 Buy
200-day EMA: 28.4 Buy

The Bank of Nova Scotia Earnings Growth & BNS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.27 per share, an increase next quarter of $0.08 per share, an increase this year of $0.96 per share, and an increase next year of $0.71 per share.

Oruka Therapeutics, Inc. Earnings Growth & ORKA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.05 per share, an increase next quarter of $0.05 per share, a decrease this year of $0.14 per share, and a decrease next year of $0.31 per share.

The Bank of Nova Scotia Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Oruka Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):